Biotest AG logo

BIO3 - Biotest AG News Story

€29.6 -0.2  -0.7%

Last Trade - 4:36pm

Sector
Healthcare
Size
Mid Cap
Market Cap £1.02bn
Enterprise Value £1.35bn
Revenue £419.7m
Position in Universe 387th / 1046

BRIEF-Biotest: All Conditions Met For Creat Takeover Of Biotest

Fri 19th January, 2018 5:08pm
Jan 19 (Reuters) - BIOTEST AG  BIOG.DE : 
    * DGAP-ADHOC: BIOTEST AG: ALL CONDITIONS MET FOR CREAT 
TAKEOVER OF 
BIOTEST 
    * FOREIGN TRADE APPROVAL HAS BEEN GIVEN BY U.S. COMMITTEE ON 
FOREIGN INVESTMENT IN UNITED STATES (CFIUS) 
    * LAST REMAINING CONDITION HAS BEEN MET FOR TAKEOVER OFFER 
BY 
TIANCHENG (GERMANY) PHARMACEUTICAL HOLDINGS AG 
    * THUS UNSOLICITED TAKEOVER BID ANNOUNCED ON MAY 18, 2017 
FOR 
SHARES OF BIOTEST AG BECOMES EFFECTIVE 
    * IN CONNECTION WITH APPROVAL, BIOTEST HAS SIGNED AN 
AGREEMENT FOR 
SALE OF ITS U.S. COMPANIES 
 
Source text for Eikon:  ID:nEQ31pLkha  
Further company coverage:  BIOG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.